Global /Singapore /Healthcare /Drug Manufacturers - General /H02

Haw Par Corporation Ltd.

H02

• SGX: H02 • Delayed

17.21SGD 0.3%

13.40 USD

As of 5 June 2026, Haw Par Corporation Ltd. has a market cap of $2.96B USD, ranking #5476 globally and #48 in Singapore. It ranks #424 in the Healthcare sector, and #166 in the Drug Manufacturers - General industry.

Global Rank

5476

Country Rank

Sector Rank

424

Industry Rank

166

Key Stats

Market Cap

$2.96BUSD

3.8B SGD

Enterprise Value

$2.38BUSD

3.05B SGD

Revenue (TTM)

$179.11MUSD

229.97M SGD

EBITDA (TTM)

$57.03MUSD

73.26M SGD

Net Income (TTM)

$206.75MUSD

265.46M SGD

EBITDA Margin

32%

Profit Margin

115%

PE Ratio

14.3

Forward PE

13.8

PS Ratio

16.5

PB Ratio

0.9

EV/EBITDA

39.0

Company Profile

Country (HQ)

Singapore

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ee Lim Wee open_in_new

Employees

595

Founded

1969

Website

hawpar.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.3%	-4%	0.5%	4.4%	15%	9.4%	33%	78%	28%

News

Markets

Exchange	Ticker	Price	Quotes
Singapore Exchange (SGX) MIC: XSES PRIMARY	H02 Haw Par Corp Ltd ISIN: SG1D25001158 Shares Out.: Shares Outstanding: 221.368M¹ Shares Float: 133.493M² TV: TradingView: SGX: H02 SA: Stock Analysis: SGX: H02 YF: Yahoo Finance: H02.SI GF: Google Finance: SGX: H02 BA: Barron's: H02 MS: Morningstar: XSES: H02	17.21 SGD	TV: TradingView: SGX: H02 SA: Stock Analysis: SGX: H02 YF: Yahoo Finance: H02.SI GF: Google Finance: SGX: H02 BA: Barron's: H02 MS: Morningstar: XSES: H02
OTC Markets (OTCMKTS / OTC) MIC: OTCM	HAWPF Haw Par Corp Ltd ISIN: SG1D25001158 TV: TradingView: OTC: HAWPF SA: Stock Analysis: OTC: HAWPF YF: Yahoo Finance: HAWPF GF: Google Finance: OTCMKTS: HAWPF BA: Barron's: HAWPF MS: Morningstar: PINX: HAWPF	10.62 USD	TV: TradingView: OTC: HAWPF SA: Stock Analysis: OTC: HAWPF YF: Yahoo Finance: HAWPF GF: Google Finance: OTCMKTS: HAWPF BA: Barron's: HAWPF MS: Morningstar: PINX: HAWPF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Haw Par Corporation Ltd.

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development; and owning and letting properties; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.

Similar Companies

Industry: Drug Manufacturers - General (Singapore)

Name	Market Cap (USD) diff.	PE	Country
iX Biopharma Ltd. SGX: 42C	$302.45M 388.34M SGD -90%	-	Singapore
Hyphens Pharma International Ltd. SGX: 1J5	$84.2M 108.1M SGD -97%	18.8	Singapore
Pharmesis International Ltd. SGX: BFK	$8.76M 11.25M SGD -100%	-	Singapore

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 26K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 18K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 12K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 11K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 10K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 9K%	20.5	Switzerland

chevron_leftBack